T here are accumulating data to suggest that disturbances in calcium metabolism may be important in the pathophysiology of hypertension.
T here are accumulating data to suggest that disturbances in calcium metabolism may be important in the pathophysiology of hypertension. 1 In relation to this hypothesis, studies have revealed abnormalities in 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) metabolism in the spontaneously hypertensive rat (SHR) compared with its control, the Wistar-Kyoto (WKY) rat. 2 -7 Investigations in human subjects with hypertension have also uncovered subpopulations with abnormal levels of circulating 1,25(OH) 2 D 3 .8 Although these studies have focused on the relation of 1,25(OH) 2 D 3 to calcium metabolism, it is entirely possible that 1,25(OH) 2 D 3 may exert a direct effect on vascular smooth muscle cell (VSMC) physiology. The recent demonstration that receptors for 1,25(OH) 2 D 3 exist in VSMC underlines this possibility. 9 To examine this question, we investigated the effect of 1,25(OH) 2 D 3 on the growth of cultured rat VSMC and reported that 1,25(OH) 2 D 3 suppresses VSMC growth; fur- aspirated, and cells were washed twice with HBSS. An aliquot of 50 fi\ 0.05% trypsin with 0.5 mM EDTA (Grand Island Biological, Grand Island, New York) was added to each well; cells were harvested onto glass fiber filters and were washed with distilled water with a semiautomatic cell harvester (Titertek Cell Harvester, Flow Labs Inc., Rockville, Maryland). Filter discs were punched out, transferred to scintillation vials containing Aquasol-2 (New England Nuclear), and counted in an LS-7000 Scintillation Counter (Beckman Instruments, Inc., Fullerton, California). All experiments were performed at least three times.
For experiments in which we wished to determine if there was a requirement for the concomitant presence of 1,25(OH) 2 D 3 to exert its effect, cells were first incubated with 1,25(OH) 2 D 3 (10~7 M) for 72 hours, then thoroughly washed three times to rinse off 1,25(OH) 2 D 3 , and reincubated with EGF at three concentrations, lxlO" 12 M, 5x10"" M, and 2.5 xlO" 9 M, for another 48 hours. Controls consisted of cells incubated with media for 120 hours, cells incubated with 1,25(OH) 2 D 3 for 72 hours, which were then washed and cultured for another 48 hours, and cells cultured with EGF in the final 48 hours of a 120-hour incubation. The cells were pulsed with [ 3 H]thymidine in the final 16 hours of culture. In separate studies, viability of cell preparations at the end of each experimental period was assessed; viability was greater than 95% for cells from both control and experimental cultures.
Cell Counts
To verify that the effects observed with the [ 3 H] thymidine assay were reflective of changes in growth, limited experiments were performed in which cell counts were done. In these experiments, lxlO 5 VSMCs were plated onto petri dishes and cultured with various substances (see Table 1 and dissolved in 0.5 ml 0.5N NaDOH. Both supernatants and cell extracts were counted in a gamma counter, and the amount of [ 125 I]EGF bound to the cells was quantitated. Nonspecific binding was determined as cell-associated radioactivity in the presence of a 500-fold excess of unlabeled EGF. The number of cells was determined from the protein content, which was measured by a modification of the method of Lowry et al. 
Discussion
Experiments in the present study demonstrate that 1,25(OH) 2 D 3 inhibits VSMC growth; they also show that the vitamin D metabolite suppresses the mitogenic effects of EGF on VSMC proliferation. There is precedence for such an action of 1,25(OH) 2 D 3 on other cell types. Thus, the substance has been shown to suppress the growth of various cancer cells 13 -15 as well as the proliferation of immune cells. been found in the blood of the SHR (compared with the WKY rat) by two groups of investigators using two different techniques. 45 Further evidence of perturbations of 1,25(OH) 2 D 3 metabolism in the SHR was recorded by studies that demonstrated a subnormal response of the rat when subjected to stimuli that would raise the level of the hormone. 7 Critically, a recent study showed that in a model of deoxycorticosterone acetate-salt hypertension, manipulations of 1,25(OH) 2 D 3 in the diet succeeded in producing a rise of blood pressure when the level of 1,25(OH) 2 D 3 was lowered, despite an unchanged level of serum calcium, 17 which suggests a direct effect of the vitamin D metabolite on the blood pressure. The relevance of these observations to human subjects is revealed in studies that have demonstrated subpopulations of patients with abnormal levels of 1,25(OH) 2 D 3 , including one segment with a diminished level of this substance. 8 The results of our study appear to be germane to the issues involved. Thus, the proliferative rates of VSMCs in the SHR have been demonstrated to be increased compared with the WKY rat, 1819 and it may reasonably be speculated that one of the factors responsible for this abnormality is the decreased level of 1,25(OH) 2 D 3 found in these rats.
In atherosclerosis, one of the key events in the genesis of the atherosclerotic lesion appears to be VSMC proliferation (reviewed in Reference 20) . Among the events leading to such VSMC proliferation may be interactions between infiltrating monocytes and macrophages and VSMCs. Macrophage products have previously been shown to stimulate VSMC proliferation. 21 Recent studies have also shown that activated macrophages elaborate 1,25(OH) 2 D 3 . 22 Our finding that 1,25(OH) 2 D 3 suppresses VSMC growth would suggest that the activated macrophage can secrete both stimulatory and inhibitory factors; the net result on the VSMC would depend on the relative amounts and potencies of the substances produced. At a clinical level, it may be of interest to determine if patients with severe atherosclerosis have any abnormality in 1,25(OH) 2 D 3 metabolism. In the clinical syndrome of chronic renal failure, there is a high incidence of atherosclerotic heart disease in such patients, many of whom also have diminished levels of circulating 1,25(OH) 2 D 3 . Although it is acknowledged that there are many potential causes of atherosclerosis in these patients, such as hypertension and disorders of lipid metabolism, it is entirely reasonable to suggest that this perturbation of 1,25(OH) 2 D 3 metabolism may be a contributing factor. Similar consideration may apply to the genesis of hypertension in these subjects.
